Inhibition of human neutrophil oxidative burst by pyrazolone derivatives by Costa, David et al.
Original Contribution
Inhibition of human neutrophil oxidative burst by pyrazolone derivatives
David Costa a, Alexandra P. Marques b, Rui L. Reis b, Jose´ L. F. C. Lima a, Eduarda Fernandes a,*
a REQUIMTE, Departamento de Quı´mica-Fı´sica, Faculdade de Farma´cia, Universidade do Porto, Rua Anı´bal Cunha, 164, 4099-030 Porto, Portugal
b 3B’s Research Group-Biomaterials, Biodegradables, Biomimetics, Department of Polymer Engineering, University of Minho,
Campus de Gualtar, 4710-057 Braga, Portugal
Received 6 September 2005; accepted 15 September 2005
Available online 21 October 2005
Abstract
The risk of agranulocytosis associated with the use of pyrazolone drugs at therapeutical doses and for short periods of time has been considered
to be very low. However, little or no attention at all has been devoted to the possible hindrance of neutrophil burst and scavenging of neutrophil-
generated reactive oxygen species (ROS) by these compounds. Such an effect could be beneficial in the case of overactivation of neutrophils but
could also be highly detrimental if the number of circulating neutrophils is already decreased. Thus, the aim of the present study was to evaluate
the putative inhibitory effect of the pyrazolones dipyrone, aminopyrine, isopropylantipyrine, and antipyrine against human neutrophil burst and
their scavenging activity against O2
S!, H2O2, HOS, ROOS, and HOCl. The obtained results showed that dipyrone and aminopyrine prevent
phorbol-12-myristate-13-acetate-induced neutrophil burst with high efficiency, while isopropylantipyrine had little effect and antipyrine had no
effect at all. Dipyrone and aminopyrine were highly potent scavengers of HO
S
and HOCl, while, in accordance with the neutrophil burst results,
isopropylantipyrine had little effect and antipyrine had no effect at all against these two ROS. None of the studied pyrazolones was capable of
scavenging O2
S! or H2O2, while dipyrone was shown to be the most reactive against ROOS.
D 2005 Elsevier Inc. All rights reserved.
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Introduction
Neutrophils (polymorphonuclear leukocytes; PMNs) are the
most abundant leukocytes of the blood and participate actively
in the innate host defence response. During this response,
PMNs and other phagocytic cells are mobilized to sites of
injury or infection where they ingest and kill invading
microorganisms [1]. These are also the first type of cells to
arrive at an inflammatory site where they play a major role in
the inflammation and tissue damage of noninfectious diseases
such as arthritis, inflammatory bowel disease, and ischemia–
reperfusion injury [2].
PMNs use an extraordinary array of oxygen-dependent and
oxygen-independent microbicidal weapons to destroy and
remove infectious agents. Oxygen-dependent mechanisms
involve the production of reactive oxygen species (ROS) and
oxygen-independent mechanisms include most other neutrophil
functions, such as chemotaxis, phagocytosis, degranulation,
and release of lytic enzymes and bactericidal peptides [3]. The
generation of ROS from stimulated neutrophils is thought to
play an important role in host defence and tissue damage [4,5].
When neutrophils are activated on contact with soluble stimuli
or by ingestion of foreign materials into phagosomes (phago-
cytosis), they initiate a ‘‘respiratory burst’’ by consuming
molecular oxygen (O2), resulting in the formation of superox-
ide radical (O2
S!) via the action of a plasma-membrane
NADPH oxidase [3,6]. The function of NADPH oxidase in
PMNs is thus to provide ROS that kill organisms. O2
S! is
important as the primary product for the neutrophil-induced
generation of ROS but is quickly converted to H2O2
spontaneously or by the enzyme superoxide dismutase (SOD)
[6]. H2O2 is not an inherently reactive compound. However,
H2O2 can be transformed into highly reactive and deleterious
products: (i) the interactions of H2O2 with O2
S! or with trace
levels of transition metals can lead to the formation of hydroxyl
radicals (HO
S
) [7]; (ii) myeloperoxidase (MPO), a hydrogen
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peroxide oxidoreductase that is specifically found in mamma-
lian granulocytic leukocytes, including neutrophils, monocytes,
basophils, and eosinophils, contributes considerably to the
bactericidal capabilities of these cells via formation of HOCl
from H2O2 and chlorine ions [8].
Although the responses of neutrophils to different stimulat-
ing conditions and pathogens are generally beneficial for host
defense, they can be deleterious to the organism if these cells
are inappropriately activated. In this sense, overproduction of
free radicals and proteolytic enzymes used as defenses against
bacteria and microorganisms can be highly toxic to surround-
ing cells and tissues [9].
Dipyrone (metamizol), aminopyrine (4-dimethylaminoanti-
pyrine; aminophenazone), isopropylantipyrine (propyphena-
zone), and antipyrine (phenazone) (Fig. 1), are pyrazolone
derivatives, pertaining to the first groups of compounds used as
analgesic, antipiretic, and antiinflammatory therapeutical drugs
[10–12], antipyrine being first prepared in 1883 [10]. The
therapeutic activity of antipyrine was increased by an intro-
duction of an isopropyl group on C-4 to produce isopropy-
lantipyrine, which improved the antipyretic and analgesic
properties, while maintaining the antiinflammatory activity
[10]. The introduction of a dimethylamino group on C-4 of the
antipyrine molecule resulted in aminopyrine (4-dimethylami-
noantipyrine) [10]. A disadvantage of aminopyrine is it relative
insolubility in water. The search for more soluble compounds
led to the production of the sodium salt of antipyrinyl-
methylaminomethane-sulfonic acid (dipyrone) [10].
The pharmacological mechanism of action of pyrazolones
is not completely understood, but it is known that it involves
the inhibition of cycloxygenase isoenzymes, platelet trombox-
ane synthesis, and prostanoids synthesis [13–15]. Unfortu-
nately, in several cases, the use of pyrazolones, more
specifically of dipyrone and aminopyrine, has been followed
by a severe decrease in the number of circulating neutrophils
(agranulocytosis) [15–17]. Because of the risk of agranulo-
cytosis, pyrazolones have been banned or withdrawn from the
market in various countries. Nevertheless, these drugs are still
available in some countries in Europe including Germany,
France, Spain, and Portugal [18]. Pyrazolones are also still
widely used in many parts of the world, including the Far
East, Africa, and Latin and South America [19], and have
been found in some herbal pain remedies (the use of which
was also reported to cause agranulocytosis) [20]. Annual sales
figures of pyrazolones amount to kilotons, mainly dipyrone
and propyphenazone [13].
The absolute risk of agranulocytosis associated with the use
of pyrazolone drugs at therapeutical doses and for short periods
of time has been considered to be very low [17]. Nevertheless,
several studies found strong evidence indicating that the
mechanism of pyrazolone-induced agranulocytosis involves
the oxidation of these compounds into a reactive intermediate,
which then reacts with neutrophils [16]. The possible liability
of pyrazolones under prooxidant conditions requires an
extensive study on the reactivity of these drugs with
neutrophil-produced ROS. On the other hand, little attention
has been devoted to the possible hindrance of neutrophil burst
by pyrazolones. Such an effect could be beneficial in the case
of overactivation of neutrophils, but it can also be highly
detrimental if the number of circulating neutrophils is already
low. Thus, having in mind the possible importance of
pyrazolone reactivity with neutrophil-produced ROS and the
pyrazolone-induced hindrance of neutrophil burst, the aim of
the present study was to evaluate the putative scavenging
activity of the above-mentioned pyrazolones against O2
S!,
H2O2, HO
S
, ROO
S
, and HOCl and their inhibitory effect against
phorbol-12-myristate 13-acetate (PMA)-induced neutrophil
burst.
Materials and methods
Materials
Dipyrone, aminopyrine, antipyrine, hypoxanthine, xanthine
oxidase grade I from buttermilk (EC 1.1.3.22), tiron, ethyle-
nediaminetetraacetic acid (EDTA) disodium salt, ascorbic acid,
sodium hypochlorite solution with 4% available chlorine, lipoic
acid, luminol, lucigenin, ferrous chloride, phorbol 12-myristate
13-acetate, histopaque-1077, histopaque-1119, Trypan blue,
diphenyleneiodonium chloride (DPI), superoxide dismutase
(SOD) (EC 1.15.1.1), Dulbecco’s phosphate-buffered saline,
without Ca2+ and Mg2+ (PBS), and myeloperoxidase from
human leukocytes (EC 1.11.1.7) were obtained from Sigma
Chemical Co. (St. Louis, MO, USA). Trolox, dimethyl
sulfoxide (DMSO), Tris (hydroxymethyl)aminomethane (Tris
buffer), and a,aV-azodiisobutyramidine dihydrochloride
(AAPH) were obtained from Fluka Chemie GmbH (Steinheim,
Germany). Fluorescein sodium salt was obtained from Aldrich
(Steinheim, Germany). Hydrogen peroxide (30% solution),
sodium carbonate, disodium hydrogen phosphate, and sodium
chloride were obtained from Merck (Darmstadt, Germany). 4-
Fig. 1. Chemical structure of dipyrone, aminopyrine, isopropylantipyrine, and
antipyrine.
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Aminobenzoic acid hydrazide (ABAH) was obtained from
Calbiochem (San Diego, CA, USA). Isopropylantipyrine was a
gift from Novartis International Pharmaceutical Ltd. (Ireland).
Measurement of ROS scavenging activity using in vitro
noncellular systems
All measurements were performed in a microplate reader
(Synergy HT; BIO-TEK), with fluorimetric or chemilumines-
cence detection.
Measurement of O2
S! scavenging activity
The O2
S! scavenging activity was measured by chemilumi-
nescence, by monitoring the O2
S! elicited oxidation of
lucigenin, according to a described procedure [21,22] with
modifications. O2
S! are generated by an hypoxanthine/xanthine
oxidase system. This system can be used because none of the
studied compounds inhibits xanthine oxidase within the tested
concentrations. Reaction mixtures contained, in a final volume
of 250 AL, the following reagents at the indicated final
concentrations: carbonate buffer (0.5 M; pH 10), lucigenin
(154 AM), hypoxanthine (0.4 mM), tested compounds dis-
solved in buffer at various concentrations (0–5 mM), and
xanthine oxidase (150 mU/mL). The resulting chemilumines-
cence was followed for 5 min. The effects are expressed as the
percentage inhibition of the O2
S!-elicited lucigenin oxidation.
Tiron was used as a positive control. Each study corresponds to
four experiments performed in triplicate.
Measurement of H2O2 scavenging activity
The H2O2 scavenging activity was measured by chemilu-
minescence, by monitoring the H2O2-induced oxidation of
lucigenin, according to a described procedure [23]. Reaction
mixtures contained, in a final volume of 250 AL, the
following reagents at the indicated final concentrations:
Tris–HCl buffer (50 mM; pH 7.4), lucigenin (3 mM), tested
compounds dissolved in buffer at various concentrations (0–5
mM), and H2O2 (2%). The resulting chemiluminescence was
followed for 5 min. The effects are expressed as the
percentage inhibition of the H2O2-induced lucigenin oxida-
tion. Ascorbic acid and catalase were used as positive
controls. Each study corresponds to four experiments per-
formed in triplicate.
Measurement of HO
S
scavenging activity
The HO
S
scavenging activity was measured by chemilumi-
nescence, by monitoring the HO
S
-elicited oxidation of luminol,
according to a described procedure [24] with modifications.
HO
S
were generated by a Fenton system (FeCl2-EDTA-H2O2).
Reaction mixtures contained, in a final volume of 250 AL, the
following reagents at the indicated final concentrations:
carbonate buffer (0.5 M; pH 10), luminol (20 AM), FeCl2-EDTA
(25 AM, 100 AM), tested compounds dissolved in buffer at
various concentrations (0–15 AM), and H2O2 (3.5 mM). The
iron salt was premixed with the chelator dissolved in water
before addition to the reaction mixture. This assay was
performed at 37-C. The resulting chemiluminescence was
followed for 5 min. The scavenging effects are expressed as
the percentage inhibition of the HO
S
-elicited luminol oxidation.
Trolox was used as a positive control. Each study corresponds to
four experiments performed in triplicate.
Measurement of HOCl scavenging activity
The HOCl scavenging activity was measured by chemilu-
minescence, by monitoring the HOCl-elicited oxidation of
luminol, according to a described procedure [25] with
modifications. HOCl was prepared immediately before use,
by adjusting the pH of a 1% (v/v) solution of NaOCl to 6.2
with diluted sulfuric acid. The concentration of HOCl was
further determined spectrophotometrically at 235 nm using the
molar absorption coefficient of 100 M!1 cm!1 [26]. Reaction
mixtures contained, in a final volume of 250 AL, the following
reagents at the indicated final concentrations: phosphate buffer
(50 mM; pH 12), luminol (250 AM), tested compounds
dissolved in buffer at various concentrations (0–5 mM), and
HOCl (25 AM). This assay was performed at 37-C. The
resulting chemiluminescence was followed for 10 s. The
scavenging effects are expressed as the percentage inhibition
of the HOCl-induced luminol oxidation. Lipoic acid was used
as a positive control. Each study corresponds to four experi-
ments performed in triplicate.
Measurement of ROO
S
scavenging activity
ROO
S
scavenging activity was measured by monitoring the
fluorescence decay as result of ROO
S
-induced oxidation of
fluorescein, according to a described procedure [27] known as
the oxygen radical absorbance capacity (ORAC) assay. ROO
S
are generated by AAPH in a microplate reader at 37-C. Reaction
mixtures contained, in a final volume of 200 AL, the following
reagents at the indicated final concentrations: phosphate buffer
(75 mM; pH 7.4), fluorescein (61 nM), tested compounds
dissolved in buffer at various concentrations (0–8 AM), and
AAPH (19 mM). Fluorescence measurements were performed
on amicroplate reader with excitation and emission wavelengths
of 485 and 528 nm, respectively. The effects are expressed as the
relative trolox equivalent ORAC value, which is calculated by
the equation: Relative ORAC Value = [(AUCsample!AUCblank)/
(AUCtrolox!AUCblank)] " (molarity of trolox/molarity of the
compound), where AUC is the area under curve [28]. Ascorbic
acid was used as a positive control. Each study corresponds to
four experiments performed in triplicate.
Measurement of PMA-induced oxidative burst in human
neutrophils
This study was performed using neutrophils isolated from
healthy human volunteers. Essentially, the study was based on
the stimulation of human neutrophils with PMA with the
subsequent measurement of the neutrophil-ROS-generating
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capacity. For this purpose, chemiluminescence methods, using
luminol and lucigenin as probes, were adapted to a microplate
reader.
As described below, the detection of ROS was evaluated by
using ROS-induced oxidation of luminol as the measured
endpoint while the specific detection of O2
S! was evaluated by
using O2
S! induced oxidation of lucigenin as the measured
endpoint.
Isolation of neutrophils. Venous blood was collected from
healthy human volunteers by antecubital venipuncture, into
EDTA vacuum tubes. Whole venous blood was separated
into cell types using histopaque solutions 1077 and 1119 in
polypropylene 12-mL centrifuge tubes, as reported before
[29], with modifications. Briefly, 3 mL of histopaque 1077
was carefully layered on top of 3 mL of histopaque 1119 in
a 12-mL polypropylene tube. Then 6 mL of the collected
blood was decanted on top of this discontinuous density
gradient. The tube was centrifuged at 800g for 30 min at
20-C. Once the centrifugation was complete the neutrophils
were carefully removed using a Pasteur pipette. The
neutrophil pellet was removed and doubled in volume using
PBS (this reduces the viscosity of the histopaque-neutrophil
suspension so that the cells can be centrifuged without the
need for high g forces); the neutrophils were centrifuged at
700g for 5 min at 4-C. The supernatant was decanted and a
mixture of 1.25 mL of PBS + 5.25 mL of sterile distilled water
was added to the neutrophil pellet to lyse any remaining red
blood cells. The tube was gently inverted for 1 min after which
isotonicity was reestablished by adding 2.2 mL of 3% NaCl.
This suspension was then submitted to a new centrifugation at
700g for 5 min at 4-C after which the supernatant was decanted
and the neutrophil pellet resuspended in PBS. The obtained cell
suspensions contained more than 99% of neutrophils and the
control of their viability showed more than 95% of the cells
excluding Trypan blue (0.4%). Isolated neutrophils were kept in
ice until use. The neutrophils were used from one volunteer per
experiment.
Oxidation of luminol by neutrophil-generated ROS. The
measurement of neutrophil burst was measured by chemilu-
minescence, by monitoring ROS-induced oxidation of lumi-
nol, according to a previously described procedure [30], with
modifications. Reaction mixtures contained, in a final volume
of 200 AL, the following reagents at the indicated final
concentrations: neutrophils (final suspension = 106 cells/mL),
tested compounds at various concentrations (0–2 mM),
luminol (500 AM), and PMA (1.6 " 10!7 M). Cells and
tested compounds were preincubated for 5 min at 37-C before
the addition of luminol and PMA. The measurements were
carried out at 37-C. Kinetic readings were initiated immedi-
ately after cell stimulation. Measurements were taken at the
peak of the curve. In all experiments, this peak was observed
around 5 min. The effects are expressed as the percentage
inhibition of the luminol oxidation. Lipoic acid was used as a
positive control. Each study corresponds to four experiments
performed in triplicate.
Oxidation of lucigenin by neutrophil-generated O2
S!. The
measurement of neutrophil burst was measured by chemilu-
minescence, by monitoring O2
S! induced oxidation of luci-
genin, according to a previously described procedure [30],
with modifications. Reaction mixtures contained, in a final
volume of 200 AL, the following reagents at the indicated final
concentrations: neutrophils (final suspension = 5 " 106 cells/
mL), tested compounds at various concentrations (0–2 mM),
lucigenin (125 AM), and PMA (1.6 " 10!7 M). The
measurements were carried out at 37-C. Kinetic readings were
initiated immediately after cell stimulation. Measurements were
taken at the peak of the curve. In all experiments, this peak was
observed around 5 min. The effects are expressed as the
percentage inhibition of lucigenin oxidation. Tiron, DPI, and
SOD were used as positive controls. Each study corresponds to
four experiments performed in triplicate.
Luminol oxidation by HOCl generated by purified
myeloperoxidase
The oxidation of luminol by purified-MPO-generated
HOCl was performed according to a previously described
procedure [31], with modifications. Reaction mixtures
contained, in a final volume of 250 AL, the following
reagents at the indicated final concentrations: NaCl (100
mM), luminol (250 AM), tested compounds at various
concentrations (0–2 mM), MPO (0.5 U/mL), and H2O2
(100 AM). Kinetic readings were initiated immediately after
addition of H2O2. All measurements were carried out at
constant temperature of 37-C, and were taken at the peak of
the curve. In all experiments, this peak was observed around
7 to 9 min. The inhibitory effects of the tested compounds are
expressed as the percentage inhibition of the luminol
oxidation. ABAH, a MPO inhibitor, was used as positive
control. Each study corresponds to four experiments per-
formed in triplicate.
Results
O2
S! scavenging activity
No scavenging activity was observed for any of the tested
nonsteroidal antiinflamatory drugs (NSAIDs) at concentrations
up to 5 mM. An IC50 of 3.7 T 0.7 AM (mean T SEM) was found
for the positive control, tiron (Table 1).
H2O2 scavenging activity
No scavenging activity was observed for any of the
tested NSAIDs at concentrations up to 5 mM. IC50s of
1035 T 33 AM (Table 1) and 50 T 5 U/mL (mean T SEM)
were found for the positive controls ascorbic acid and
catalase, respectively.
HO
S
scavenging activity
Fig. 2 shows the results obtained in the HO
S
scavenging
assay. Dipyrone, aminopyrine, isopropylantipyrine, and anti-
pyrine prevented HO
S
-induced luminol oxidation in a concen-
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tration-dependent manner. Dipyrone and aminopyrine were
much more potent scavengers than antipyrine and isopropy-
lantipyrine. The evaluated IC50s were 5.8 T 0.5, 2.1 T 0.4,
2393 T 424, and >5000 AM (mean T SEM) for dipyrone,
aminopyrine, isopropylantipyrine, and antipyrine, respectively
(Table 1). An IC50 of 0.70 T 0.07 AM (mean T SEM) was
found for the positive control, trolox.
HOCl scavenging activity
Fig. 3 shows the results obtained in the HOCl scavenging
assay. Dipyrone, aminopyrine, isopropylantipyrine, and
antipyrine prevented the HOCl-induced oxidation of luminol
in a concentration-dependent manner. In accordance with the
results obtained in the HO
S
scavenging assay, dipyrone and
aminopyrine were also much more potent scavengers than
antipyrine and isopropylantipyrine. The evaluated IC50s were
4.5 T 0.7, 20.2 T 2.5, 1557 T 167, and >5000 AM (mean T
SEM) for dipyrone, aminopyrine, isopropylantipyrine, and
antipyrine, respectively (Table 1). An IC50 of 6.0 T 0.5 AM
(mean T SEM) was found for the positive control, lipoic
acid.
ROO
S
scavenging activity
Table 2 shows the results obtained in the ROO
S
scavenging
assay. Again, the results obtained in this study demonstrate that
ROO
S
is effectively scavenged by dipyrone and aminopyrine,
while antipyrine is much less active and isopropylantipyrine is
devoid of any activity against this ROS (ORAC values are
2.4 T 0.3, 1.3 T 0.3, and 0.08 T 0.01 (mean T SEM) for
dipyrone, aminopyrine, and antipyrine, respectively) (Table
Table 1
Scavenging activities (IC50 AM, mean T SEM) of antipyrine, isopropylanti-
pyrine, aminopyrine, and dipyrone and the positive controls trolox, tiron,
ascorbic acid, and lipoic acid, against O2
S!, H2O2, HOS, and HOCl
Tested compound IC50 (AM)
O2
S! H2O2 HOS HOCl
Antipyrine NA NA >5000 >5000
Isopropylantipyrine NA NA 2393 T 424 1557 T 167
Aminopyrine NA NA 2.1 T 0.4 20.2 T 2.5
Dipyrone NA NA 5.8 T 0.5 4.5 T 0.7
Trolox — — 0.70 T 0.07 —
Tiron 3.7 T 0.7 — — —
Ascorbic acid — 1035 T 33 — —
Lipoic acid — — — 6.0 T 0.5
NA, no activity was found within the tested concentrations (up to 5000 AM).
Fig. 2. HO
S
scavenging activity of dipyrone, aminopyrine, isopropylantipyrine,
and antipyrine as determined by their ability to prevent HO
S
-elicited oxidation
of luminol. Each point represents the values obtained from four experiments
performed in triplicate (mean T SEM).
Fig. 3. HOCl scavenging activity of dipyrone, aminopyrine, isopropylantipyr-
ine, and antipyrine as determined by their ability to prevent HOCl-elicited
oxidation of luminol. Each point represents the values obtained from four
experiments performed in triplicate (mean T SEM).
D. Costa et al. / Free Radical Biology & Medicine 40 (2006) 632–640636
2). The ORAC value found for the positive control ascorbic
acid was 0.25 T 0.07 (mean T SEM).
Inhibition of neutrophil burst
The measurement of neutrophil burst was performed in two
complementary assays. In the first assay the neutrophil burst
was measured by chemiluminescence, by monitoring ROS-
induced oxidation of luminol (Fig. 4). It can be observed that
all the tested compounds, except antipyrine, were effective
inhibitors of the neutrophil burst, dipyrone being the most
active. Aminopyrine was also highly effective in preventing the
neutrophil burst, at the same concentrations as dipyrone, but
isopropylantipyrine displayed only weak inhibitory activity, yet
still similar to that of lipoic acid. IC50 values were 13.4 T 3.5,
25.0 T 4.0, and 1410 T 427 AM (mean T SEM) for dipyrone,
aminopyrine, and isopropylantipyrine, respectively, while the
IC50 values found for the positive control lipoic acid was 943 T
271 AM (mean T SEM) (Table 3).
In a second assay, the neutrophil burst was also measured by
chemiluminescence, by monitoring O2
S! induced oxidation of
lucigenin. In this assay no inhibitory activity was found for the
tested compounds up to the concentration of 2000 AM. The
IC50 values found for the positive controls DPI (inhibitor of
NADPH oxidase), tiron (scavenger of O2
S!), and SOD were
1.1 T 0.1 AM, 88.0 T 10.0 AM, and 59 T 4 U/mL (mean T SEM),
respectively (Table 3).
Luminol oxidation by MPO-generated HOCl
Fig. 5 shows the results obtained in the oxidation of luminol
by MPO-generated HOCl. In this assay effective activity was
Fig. 4. Inhibition (%) of neutrophil-generated ROS-induced oxidation of luminol
by dipyrone, aminopyrine, and isopropylantipyrine. Each point represents the
values obtained from four experiments performed in triplicate (mean T SEM).
Table 3
Inhibition of neutrophil burst by antipyrine, isopropylantipyrine, aminopyrine,
dipyrone, diphenyleneiodonium chloride (DPI), tiron, lipoic acid, 4-amino-
benzoic acid (ABAH) (IC50 AM, mean T SEM), and superoxide dismutase
(SOD) (IC50 U/mL, mean T SEM)
Tested compound IC50 (AM)
Neutrophils–
luminol
Neutrophils–
lucigenin
MPO–
luminol
Antipyrine NA NA NA
Isopropylantipyrine 1410 T 427 NA NA
Aminopyrine 25.0 T 4.0 NA 33.3 T 3.0
Dipyrone 13.4 T 3.5 NA 5.6 T 0.3
DPI — 1.1 T 0.1 —
Tiron — 88.0 T 10.0 —
Lipoic acid 943 T 271 — —
ABAH — — 0.34 T 0.01
SOD (U/mL) — 59 T 4 —
NA, no activity was found within the tested concentrations (up to 2000 AM).
Fig. 5. Inhibition (%) of luminol oxidation by myeloperoxidase (from human
leukocytes)-generated HOCl by dipyrone and aminopyrine. Each point
represents the values obtained from four experiments performed in triplicate
(mean T SEM).
Table 2
ROO
S
scavenging activity (mean T SEM) of antipyrine, isopropylantipyrine,
aminopyrine, dipyrone, and ascorbic acid, as measured by monitoring the
fluorescence decay in result of ROO
S
-induced oxidation of fluorescein, known
as oxygen radical absorbance capacity (ORAC) assay
Tested compound ORACROOS T SEM
(AM trolox equivalents/AM compound)
Antipyrine 0.08 T 0.01
Isopropylantipyrine NA
Aminopyrine 1.31 T 0.29
Dipyrone 2.37 T 0.31
Ascorbic acid 0.25 T 0.07
Values are presented as the relative potency to the positive control trolox. NA,
no activity was found.
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observed only for dipyrone and aminopyrine, which, never-
theless, were shown to be highly potent compounds, with IC50
values of 5.6 T 0.3 and 33.3 T 3.0 AM (mean T SEM),
respectively (Table 3). The IC50 value found for the positive
control ABAH was 0.34 T 0.01 AM (mean T SEM) (Table 3).
Discussion
The results obtained in the present study confirm that
aminopyrine and dipyrone prevent PMA-induced neutrophil
burst with high efficiency, while isopropylantipyrine had little
effect and antipyrine had no effect at all. In general, the
inhibition of neutrophil burst can be due either to the inhibition
of ROS-generating enzymes or to the direct ROS-scavenging
effect. Taking into consideration that the main ROS produced
by neutrophils are NADPH-oxidase-generated O2
S! (with sub-
sequent formation of H2O2, HO
S
, and ROO
S
) [3,6] and MPO-
generated HOCl [8], it was of great interest to evaluate the
scavenging effect of the studied pyrazolones against these
species. It was clearly shown that aminopyrine and dipyrone
were highly potent scavengers of HO
S
and HOCl
S
, while, in
accordance with the neutrophil burst results, isopropylantipyr-
ine had little effect and antipyrine showed only a residual effect
against these two ROS. None of the studied pyrazolones was
capable of scavenging O2
S! or H2O2, while dipyrone was
shown to be the most reactive against ROO
S
.
Most of the neutrophil burst and purified human MPO
assays, including those performed in the present study, use the
oxidation of luminol or lucigenin as the measured endpoints.
While luminol can be oxidized by several ROS [30], lucigenin
is oxidized mainly by O2
S! [30] or H2O2 [23]. With regard to
the direct effect of the studied NSAIDs on the activity of MPO
purified from human leucocytes, it was demonstrated that
aminopyrine and particularly dipyrone prevented the MPO-
induced oxidation of luminol with high efficacy. Importantly,
aminopyrine was previously shown to have a strong inhibitor
effect against MPO, while antipyrine and 4-aminoantipyrine
had no effect [32]. Thus, it may be postulated that the observed
scavenging effects of aminopyrine and dipyrone against HO
S
and HOCl, together with the direct MPO inhibition by
aminopyrine, should contribute to the prevention of neutrophil
burst and MPO-induced oxidation of luminol. This was
confirmed by the observed lack of inhibitory effects when
the oxidation of lucigenin was the measured endpoint. Indeed,
in this case, no inhibitory effect was observed for any of the
tested pyrazolones, which is in agreement with the absence of
O2
S! scavenging activity observed for these compounds. These
last results also indicate that none of the studied compounds
have NADPH oxidase inhibitor effects.
The observed reactivity of pyrazolones against neutrophil-
produced ROS may also help to understand their possible
contribution to agranulocytosis. Two major types of agranu-
locytosis induced by drugs have been described, one of an
immunological type, which is caused by drug-induced
antibodies, and another of a toxic type, where the offending
agent drug and/or its metabolites suppress cell production in
the bone marrow [33]. With regard to the pyrazolones tested
in the present work, aminopyrine has long been associated
with a high incidence of agranulocytosis [16] and is the
best-characterized drug with regard to its chemical and
biological reactivity. Indeed, several studies found strong
evidence indicating that the mechanism of aminopyrine-induced
agranulocytosis involves a drug-dependent antineutrophil anti-
body that requires covalent binding of the drug, or, most
probably, a reactive derivative of the drug, to neutrophils [16].
The generation of an aminopyrine-reactive derivative can be
accomplished through its oxidation. In the present study, it was
observed that aminopyrine and dipyrone are highly reactive with
HO
S
, ROO
S
, and HOCl. The oxidation of aminopyrine by
neutrophil-MPO-generated HOCl was previously reported,
leading to the formation of a blue cation radical (AP
S+), to
which has been attributed the potentially fatal bone marrow
toxicity, leading to agranulocytosis [34,35]. It has been proposed
that the mechanism by which HOCl oxidizes aminopyrine to a
cation radical involves N-chlorination followed by loss of a
chlorine radical [35]. Another possible mechanism is the
formation of a dication by the loss of chloride ion from N-
chloroaminopyrine [16]. This intermediate is very reactive, with
a half-life of approximately 15 ms, and, in addition to being the
precursor of the cation radical, it also appears to react with two
molecules of water to form several other products that are
consistent with the proposed dication intermediate [16]. Thus,
according to Uetrecht et al. [16], the reactive dication formed
by neutrophil-derived HOCl could also be responsible for
aminopyrine-induced agranulocytosis.
The formation of AP
S+ has also been shown to be mediated
by other enzymatic systems, namely by prostaglandin H
synthase [36], lipoxygenase [37], and horseradish peroxidase
[38,39]. Peroxidase-catalyzed aminopyrine metabolism
involves two N-demethylation steps which release HCHO
and form 4-methylaminoantipyrine and then aminoantipyrine
via intermediate N-cation radicals [40]. Of note, GSH prevents
aminopyrine metabolism and HCHO release by reducing the
aminopyrine N-cation radical to aminopyrine [41]. Further-
more, NADH is also oxidized by aminopyrine radicals to form
NAD+, which is accompanied by oxygen uptake and formation
of reactive oxygen species [40]. Importantly, aminoantipyrine,
a metabolite of aminopyrine and dipyrone [15,42], was found
to be more effective than aminopyrine at catalyzing GSH or
NADH oxidation [40], which contributes to the reported toxic
effect of these parent compounds.
Dipyrone is itself a prodrug that undergoes nonenzymatic
hydrolysis in the stomach to form 4-methylaminoantipyrine,
which is rapidly and almost completely absorbed [15,42].
Therefore, the agranulocytosis effect that has been attributed to
dipyrone [15,17,18] is in accordance with the above-mentioned
chemical and biological reactivity, with N-chlorination of this
metabolite, followed by loss of a chlorine radical to form a
cation radical [40].
The attribution of agranulocytosis to antipyrine and iso-
propylantipyrine is only anecdotal. However, antipyrine is a
CH-acidic compound that readily undergoes electrophilic
substitution at the 4 position, hence giving potential chemical
and biological reactivity to this molecule [43]. An acute
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allergic reaction to antipyrine was already reported [44]. 4-
Isopropylantipyrine is also mentioned as elicitor of allergic/
pseudoallergic reactions, for which only scarce data on the
nature of the underlying mechanisms are available [45]. It was
recently demonstrated that immediate-type adverse reactions to
4-isopropylantipyrine could be classified as Type I allergy and
are mediated by specific IgE antibodies [45]. Of note, a
common IgE-binding epitope for pyrazolone drugs was
previously described [46].
Although the absolute risk of agranulocytosis associated
with the use of pyrazolones has been considered to be very low,
their reactivity with neutrophil-derived HO
S
, ROO
S
, and HOCl
with possible formation of reactive intermediates capable of
inducing agranulocytosis should be taken into account. Also,
the hindrance of neutrophil burst by dipyrone and aminopyrine
may be important. As mentioned before, the MPO inhibitor
effect, together with the scavenging activity against HO
S
, ROO
S
,
and HOCl, could be beneficial in the case of overactivation of
neutrophils. However, these effects can also be highly
detrimental if the number of circulating neutrophils is already
decreased. In this sense, aminopyrine and dipyrone were the
most reactive, while antipyrine and isopropylantipyrine were
demonstrated to be the less reactive compounds. On the other
hand, these two latter pyrazolones may also be endowed with
potential adverse effects, as judged by their allergenicity.
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